Andrea Matthews insider trades

Open-market stock purchases and sales by Andrea Matthews, Chief Business Officer at Astria Therapeutics, Inc, from SEC Form 4 filings since Apr 17, 2023.

Recent trades

DateStockTradeValue
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$214K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$216K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.7M

Companies traded

  • ATXS Astria Therapeutics, Inc: other filings, last Jan 23, 2026

Get free alerts when Andrea Matthews files a new trade →